Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers

Gynecologic Oncology

Volumn 63, Issue 2, 1996, Pages 173-179

  Sakamoto, Takako ^a,b   Nomura, Nobuo ^c   Mori, Hiroyuki ^b   Wake, Norio ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CHROMOSOME 17P; CHROMOSOME BANDING PATTERN; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GENE DELETION; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE K RAS; OVARY CANCER; PRIORITY JOURNAL;

EID: 0030297740     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0302     Document Type: Article

References (25)

1. 1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis, Cell 61, 759-767 (1990).
2. 2. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science 244, 707-712 (1989).
3. 3. Fujita, M., Enomoto, T., Inoue, M., Tanizawa, O., Ozaki, M., Rice, J. M., and Nomura, T. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary, Jpn. J. Cancer Res. 85, 1247-1256 (1994).
4. 4. Sato, T., Saito, H., Morita, R., Koi, S., Lee, J. H., and Nakamura, Y. Allelotype of human ovarian cancer, Cancer Res. 51, 5118-5122 (1991).
5. 5. Gallion, H. H., Powell, D. E., Morrow, J. K., Pieretti, M., Case, E., Turker, M. S., DePriest, P. D., Hunter, J. E., and van Nagell, J. R. Molecular genetic changes in human epithelial ovarian malignancies, Gynocol. Oncol. 47, 137-142 (1992).
6. 6. Eccles, D. M., Russell, S. E. H., Haites, N. E., and The ABE Ovarian Cancer Genetics Group (Atkinson, R., Bell, D. W., Gruber, L., Hickey, I., Kelly, K., Kitchener, H., Leonard, R., Lessells, A., Lowry, S., Miller, I., Milner, B., and Steel, M.). Early loss of heterozygosity on 17q in ovarian cancer, Oncogens 7, 2069-2072 (1992).
7. 7. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Halling, K. C., Keeney, G., Podratz, K. C., and Jenkins, R. B. Human epithelial ovarian cancer allelotype, Cancer Res. 53, 2393-2398 (1993).
8. 8. Dodson, M. K., Hartmann, L. C., Cliby, W. A., DeLacey, K. A., Keeney, G. L., Ritland, S. R., Su, J. Q., Podratz, K. C., and Jenkins, R. B. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas, Cancer Res. 53, 4456-4460 (1993).
9. 9. Yang-Feng, T. L., Han, H., Chen, K. C., Li, S., Claus, E. B., Carcangiu, M. L., Chambers, S. K., Chambers, J. T., and Schwartz, P. E. Allelic loss in ovarian cancer, Int. J. Cancer 54, 546-551 (1993).
10. 10. Ginsberg, D., Mechta, F., Yaniv, M., and Oren, M. Wild-type p53 can down-modulate the activity of various promoters, Proc. Natl. Acad. Sci. USA 88, 9979-9983 (1991).
11. 11. Cornelis, R. S., van Vliet, M., Vos, C. B. J., Cleton-Jansen, A-M., van de Vijver, M. J., Peterse, J. L., Khan, P. M., Bfrresen, A-L., Cornelisse, C. J., and Devilee, P. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations, Cancer Res. 54, 4200-4206 (1994).
12. 12. Coles, C., Thompson, A. M., Elder, P. A., Cohen, B. B., Mackenzie, I. M., Cranston, G., Chetty, U., Mackay, J., Macdonald, M., Nakamura, Y., Hoyheim, B., and Steel, C. M. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis, Lancet 336, 761-763 (1990).
13. 13. Nakamura, Y., Leppert, M., O'Connell, P., Wolff, R., Holm, T., Culver, M., Martin, C., Fujimoto, E., Hoff, M., Kumlin, E., and White, R. Variable number of tandem repeat (VNTR) markers for human gene mapping, Science 235, 1616-1622 (1987).
14. 14. Matlashewski, G. J., Pim, T. D., Schneider, L. J., and Crawford, L. V. Primary structure polymorphism at amino acid residue 72 of human p53, Mol. Cell Biol. 7, 961-963 (1987).
15. 15. Fain, P. R., Black, D. M., and Solomon, E. Report of the committee on the genetic constitution of chromosome 17, in Human gene mapping 1993 (A. J. Cuticchia and P. L. Pearson, Ed.), Johns Hopkins Univ. Press, Baltimore and London, pp. 529-559 (1994).
16. 16. Murakami, Y., Hayashi, K., and Sekiya, T. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis, Cancer Res. 51, 3356-3361 (1991).
17. 17. Meltzer, S. J., Yin, J., Huang, Y., McDaniel, T. K., Newkirk, C., Iseri, O., Vogelstein, B., and Resau, J. H. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction, Proc. Natl. Acad. Sci. USA 88, 4976-4980 (1991).
18. 18. Phillips, N. J., Ziegler, M. R., Radford, D. M., Fair, K. L., Steinbrueck, T., Xynos, F. P., and Donis-Keller, H. Allelic deletion on chromosome 17p13.3 in early ovarian cancer, Cancer Res. 56, 606-611 (1996).
19. 19. Swift, A., Risk, J. M., Kingsnorth, A. N., Wright, T. A., Myskow, M., and Field, J. K. Frequent loss of heterozygosity on chromosome 17 at 17q11.2-q12 in Barrett's adenocarcinoma, Br. J. Cancer 71, 995-998 (1995).
20. 20. Hoshino, S., Kimura, A., Fukuda, Y., Dohi, K., and Sasazuki, T. Polymerase chain reaction-single-strand conformation polymorphism analysis of polymorphism in DPA1 and DPB1 genes: A simple, economical, and rapid method for histocompatibility testing, Hum Immunol. 33, 98-107 (1992).
21. 21. Imamura, T., Arima, T., Kato, H., Miyamoto, S., Sasazuki, T., and Wake, N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas, Int. J. Cancer 51, 47-52 (1992).
22. 22. Foulkels, W. D., Stamp, G. W. H., Afzal, S., Lalani, N., McFarlane, C. P., Trowsdale, J., and Cambell, I. G. MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutataion status, Br. J. Cancer 12, 883-888 (1995).
23. 23. Foulkels, W. D., Black, D. M., Stamp, G. W. H, Solomon, E., and Trowsdale, J. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma, Int. J. Cancer 54, 220-225 (1993).
24. 24. Phillips, N., Ziegler, M., Saha, B., and Xynos, F. Allelic loss on chromosome 17 in human ovarian cancer, Int. J. Cancer 54, 85-91 (1993).
25. 25. Thompson, A. M., Steel, C. M., Chetty, U., Hawkins, R. A., Miller, W. R., Carter, D. C., Forrest, A. P., and Evans, H. J. p53 gene mRNA expression and chromosome 17p allele loss in breast cancer, Br. J. Cancer 61, 74-78 (1990).